tiprankstipranks
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
6855
Ascentage Pharma Group International
RESEARCH TOOLSreports
Want to see HK:6855 full AI Analyst Report?

Ascentage Pharma Group International (6855) Financial Statements

4 Followers

Ascentage Pharma Group International Financial Overview

Ascentage Pharma Group International's market cap is currently HK$15.65B. The company's EPS TTM is HK$-3.46; its P/E ratio is -6.78; Ascentage Pharma Group International is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 559.26M¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M
Gross Profit¥ 427.35M¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M
Operating Income¥ -1.18B¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M
EBITDA¥ -1.10B¥ -299.63M¥ -743.61M¥ -835.99M¥ -915.99M
Net Income¥ -1.21B¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M
Balance Sheet
Cash & Short-Term Investments¥ 2.47B¥ 1.26B¥ 1.10B¥ 1.50B¥ 1.75B
Total Assets¥ 3.97B¥ 2.62B¥ 2.50B¥ 2.83B¥ 2.94B
Total Debt¥ 1.98B¥ 1.67B¥ 1.80B¥ 1.79B¥ 1.08B
Net Debt¥ -490.58M¥ 407.29M¥ 726.30M¥ 300.49M¥ -659.53M
Total Liabilities¥ 2.63B¥ 2.34B¥ 2.43B¥ 2.42B¥ 1.71B
Stockholders' Equity¥ 1.33B¥ 264.19M¥ 60.42M¥ 408.66M¥ 1.23B
Cash Flow
Free Cash Flow¥ -1.20B¥ -135.65M¥ -782.92M¥ -857.20M¥ -1.04B
Operating Cash Flow¥ -1.17B¥ -111.36M¥ -726.08M¥ -653.91M¥ -604.68M
Investing Cash Flow¥ -1.00B¥ -362.04M¥ 21.92M¥ -384.61M¥ -466.52M
Financing Cash Flow¥ 2.54B¥ 314.77M¥ 368.75M¥ 619.27M¥ 1.78B
Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History

Income Statement >

Ascentage Pharma Group International Debt to Assets

Balance Sheet >

Ascentage Pharma Group International Cash Flow

Cash Flow >

Ascentage Pharma Group International Forecast EPS vs Actual EPS

Earnings >